Abstract-K 2P 6.1, a member of the 2-pore domain K channel family, is highly expressed in the vascular system; however, its function is unknown. We tested the following hypotheses. K 2P 6.1 regulates the following: (1) systemic blood pressure; (2) the contractile state of arteries; (3) vascular smooth muscle cell migration; (4) 
I
n the mid to late 1990s, researchers took advantage of the fact that known K channels had a highly conserved sequence of amino acids in the K ϩ selective pore. 1 A search for mammalian genes that carried homology to this signature sequence revealed a new, previously unrecognized family of K channels named 2-pore domain K channels (K 2P , gene name Kcnk) on the basis that each protein subunit contained 2 pore-forming regions of the K ϩ selectivity filter. 2, 3 Unlike other K channels, which require 4 protein subunits, each contributing 1 pore domain to form a fully functioning channel, K 2P channels only require 2. Since the discovery of the first mammalian K 2P in 1996, 15 genes for this family have been identified. 3 One of the K 2P channels without a known function is K 2P 6.1 (Kcnk6 or TWIK-2). Unlike most other K 2P s, K 2P 6.1 is conspicuously absent from neuronal and glial cells but is expressed in a number of other tissues, such as stomach, spleen, lung, and pancreas. 4 -6 Of interest to us is the fact that K 2P 6.1 is highly expressed in all of the blood vessels studied to date, including resistance-sized vessels. 2, [7] [8] [9] [10] Thus, K 2P 6.1 is a prime candidate for physiological regulation in the vascular system. In the present study, we tested the following hypotheses. First, K 2P 6.1 regulates systemic blood pressure. Second, K 2P 6.1 in vascular smooth muscle (VSM) cells (VSMCs) regulates the contractile state of arteries. Because K channels in the vascular system are involved with other important physiological processes, we also tested the following hypotheses: K 2P 6.1 in VSMC is involved with cell migration 11 and/or proliferation, 12 and K 2P 6.1 in VSMCs is involved in volume regulation during osmotic stress 13 and/or apoptosis. 14 Because there are no selective activators or inhibitors for K 2P 6 .1, we generated a K 2P 6.1 knockout (KO) mouse for these studies. We report that K 2P 6.1-deficient mice have depolarized plasma membranes of VSMCs, increased vascular contractility, and hypertension. A mechanism that accounts for these changes may involve K 2P 6.1 setting the resting membrane potential of VSMCs.
Methods
For Methods see the online Data Supplement at http://hyper. ahajournals.org. All of the studies were approved by the Baylor College of Medicine Institutional Animal Care and Use Committee.
Results
KO mice were viable and fertile, obeyed the mendelian ratio, and showed no changes in gross body composition at 8 to 12 weeks of age ( Figure S1 for KO strategy and Table S1 for body composition analysis, both available in the online Data Supplement at http://hyper.ahajournals.org). Figure 1 shows the results of RNA detection by real-time PCR. The mRNA expression is shown as a percentage of the reference mRNA, GAPDH ( Figure 1A and 1B). A panel of 6 K 2P gene family members was probed in the thoracic aorta ( Figure 1A ) and whole heart ( Figure 1B) . A second panel of 3 non-K 2P but vascular-related targets is also shown.
Gene expression of K 2P 1.1 (TWIK-1), the closest relative to K 2P 6.1, showed no change between genotypes. Other genes that are involved with vascular function, including the K channels K Ca 1.1/␤1 and K Ca 3.1, and endothelial NO synthase (eNOS) showed no change in expression. K 2P 6.1 mRNA is absent in the KO aorta and heart (PϽ0.05; nϭ4 to 10), and there is no evidence of gene profile remodeling at the level of mRNA in selected genes as a result of this gene deletion. However, this conclusion does not account for genes not studied or posttranslational modifications as a result of K 2P 6.1 deletion.
For cell-specific expression of K 2P 6.1, aorta of Tie2-GFP (endothelial-expressing) mice were digested and sorted into GFP ϩ (RNA profile eNOS ϩ /sm22␣ Ϫ ) as the endothelial fraction and GFP Ϫ (RNA profile eNOS Ϫ /sm22a ϩ ) as the VSMC fraction. K 2P 6.1 RNA expression levels were detectable to a greater extent in the VSMCs of the thoracic aorta; however, RNA was also detected in the endothelial fraction ( Figure 1C; nϭ4) . Figure 2A shows blood pressures in awake mice obtained using tail-cuff plethysmography. Systolic and mean arterial pressures were increased in the KO mice by 34Ϯ3 and 26Ϯ3 mm Hg, respectively (nϭ6 pairs). Blood pressures in anesthetized mice confirm that KO mice were hypertensive ( Figure 2B and Figure 2B ). For a complete table of cardiovascular indices in anesthetized mice see Table S2 .
Histological examination showed that the aortic wall was Ϸ20% thicker in KO mice ( Figure S2A and S2B); however, this increase did not reach statistical significance (Pϭ0.26). Luminal diameters of the aortas were not significantly different between WT and KO mice. It is possible that major changes in vascular structure as a result of the hypertension require more than 8 to 12 weeks (the age studied) to develop.
Wire myography was performed to assess the contractile state of the aorta in the K 2P 6.1 KO and WT animals. Figure  3A shows the length-force relationship, with the KO mice generating more force to the application of 60 mmol/L of isotonic KCl (Na ϩ adjusted) with resting force between 15 and 40 mN (PϽ0.01; nϭ8). For all of the subsequent wire myography studies, we chose a resting force of 15 mN for each aorta regardless of genotype. At this resting force, aortas from both KO and WT mice contracted to 80% of their respective maximums with the addition of 60 mmol/L of KCl. Figure 3B shows the concentration response curve for increases in KCl (isotonic by reducing Na ϩ ). Aortic rings from KO mice generated greater force at each K ϩ concentration compared with aortas from WT mice (PϽ0.01; nϭ6). At 60 mmol/L, KCl aortas from the KO contracted with 54% greater force compared with the WT mice (PϽ0.01; nϭ6). The addition of 100 mol/L of N G -nitro-L-arginine methyl ester to inhibit NOS produced enhanced forces as a result of increasing extracellular K ϩ in rings from both genotypes. However, the forces generated by rings from KO mice were still greater after NOS inhibition than WT rings with differences in force being the same as without eNOS inhibition (PϽ0.001; nϭ6; data not shown). Figure 3C and 3D shows electric potentials across the membrane using the current clamp mode (iϭ0 pA) in freshly dispersed VSMCs from the aortas. An individual cell of each genotype is shown in Figure 3C with the summary data given in Figure 3D . VSMCs from KO mice were ϩ17Ϯ2 mV more depolarized compared with VSMCs from WT mice (Ϫ22Ϯ2 mV and Ϫ39Ϯ5 mV, respectively; PϽ0.05; nϭ7 for each genotype). The addition of 10 mol/L of colchicine, which prevented contraction of the cells and loss of the pipette seal, had no effect on membrane potential. Increasing KCl in the extracellular buffer from 5.4 to 60.0 mmol/L (Na ϩ adjusted) depolarized the plasma membrane of both genotypes; however, the KO maintained a significantly more depolarized state compared with the WT (PϽ0.05; nϭ7; Figure 3C and 3D). With the addition of 120 mmol/L of KCl, the difference in membrane potential between genotypes was no longer statistically different (Pϭ0.23; nϭ7; Figure 3D ). After washing with physiological KCl buffer, the initial resting membrane potentials were re-established. Cell size as determined by capacitance did not differ between genotypes (nϭ6; WT: 12.1Ϯ1.6 pF and KO: 12.5Ϯ0.8 pF; Pϭ0.85). Figure 4 shows contractile responses of aortic rings to phenylephrine, U46619, and BAY K 8644. Contractions to phenylephrine, an ␣-adrenergic agonist, were similar in aortic rings from WT and KO mice ( Figure 4A ; Pϭ0.97). However, aortic rings from KO mice generated more force with the addition of U46619, a thromboxane mimetic ( Figure 4B ; Pϭ0.01 for genotype and PϽ0.001 for interaction between genotype and U46619 concentration) and BAY K 8644, an L-type calcium channel activator ( Figure 4C ; Pϭ0.04 for genotype and PϽ0.001 for interaction between genotype and BAY K 8644 concentration). Contractions with the addition 100 mol/L of N G -nitro-L-arginine methyl ester were enhanced with all of the agonists in both genotypes compared with having no N G -nitro-L-arginine methyl ester present. The contractions to phenylephrine were similar in aortic rings from WT and KO mice (nϭ8; Pϭ0.75). However, contractions to U46619 and BAY K 8644 in the presence of N G -nitro-L-arginine methyl ester were enhanced in rings from KO compared with WT mice (nϭ6 and 5, respectively; PϽ0.01 and Pϭ0.01, respectively, for interaction between genotype and concentration). Having established differences in contractile properties of the aortic rings to KCl, U46619, and BAY K 8644, we sought to determine the role of calcium channels and rho kinase in these contractions ( Figure S3 ). After aortic rings were precontracted with 60 mmol/L of KCl, 10
Ϫ6 mol/L of U46619, or 10
Ϫ4 mol/L of BAY K 8644, changes in force were recorded with the addition of the L-type calcium channel blocker, nifedipine; the T-type calcium channel blocker, mibefradil; or the rho kinase inhibitor, Y27632. Y27632 is Ͼ100 times more potent for rho kinase than for other kinases, including protein kinase C, protein kinase A, and myosin light chain kinase. 15 From the studies described in Figure S3 , we determined the following: (1) the L-type calcium channel is the predominant channel in the mouse aorta; (2) U46619, a thromboxane mimetic, only constricts through activation of rho kinase and calcium channels are not involved; and (3) 10 Ϫ6 mol/L of nifedipine relaxed KO aortas 62% less than WT when precontracted with BAY K 8644, an L-type calcium channel activator.
In the next series of experiments, we determined whether the densities of calcium channels were different in aortic VSMCs from WT and KO mice. Studies were conducted by measuring whole cell currents using ruptured patches in the voltage clamp configuration. Ba 2ϩ , which is conducted by calcium channels, was used as a surrogate for Ca 2ϩ , because calcium channels do not inactivate as rapidly and conduct Ն4 times greater with Ba 2ϩ compare with Ca 2ϩ . 16 Figure S4 shows raw traces and summary data for currents at different voltage steps from VSMCs of WT and KO mice. There were no statistical differences in current densities between genotype at baseline (Pϭ0.46), after administration of BAY K 8644 (Pϭ0.80), or after the addition of nifedipine (Pϭ1.0). Cell size, as determined by capacitance, did not differ among genotypes (nϭ6; WT: 12.2Ϯ1.7 pF; KO: 12.7Ϯ1.0 pF; Pϭ0.8).
We conducted a study where the rho kinase inhibitor was added before the addition of BAY K 8644 ( Figure 5 ).
Preincubation with 10
Ϫ6 mol/L of Y27632 for 60 minutes had very little effect on the contractions in aortic rings from WT mice. However, Y27632 significantly reduced the contractions to BAY K 8644 in aortas from KO mice, as shown in Figure 5A (PϽ0.05, repeated measures ANOVA; nϭ6). In the presence of the rho kinase inhibitor, contractions produced by BAY K 8644 in aortas from WT and KO mice were similar. Figure 5B shows the maximum contractions elicited by 10
Ϫ4 mol/L of BAY K 8644 in the presence and absence . Concentration-response curves for (A) phenylephrine, an ␣-adrenergic agonist; (B) U46619, a thromboxane mimetic; and (C) BAY K 8644, an L-type calcium channel activator in aortic rings from wild-type (WT) and knockout (KO) mice. nϭ6 to 9 per experimental group. #PϽ0.01 using 2-way repeated-measures ANOVA, *PϽ0.05, **PϽ0.01, and ***PϽ0.001 using the Holm-Sidak method for multiple comparison.
of 10
Ϫ6 mol/L of Y27632. The data in Figure 5B are a portion of the data shown in Figure 5A but in bar chart format to emphasize effects of inhibition of rho kinase. Preincubation with Y27632 significantly decreased the contraction (Ϫ42Ϯ3%) in KO (nϭ6; PϽ0.001) but not in aortas from WT mice (Ϫ25Ϯ8%; nϭ6; Pϭ0.302). These results suggest that the KO aortas have increased rho kinase activity in the presence of BAY K 8644 compared with aortas from WT mice. There were no significant differences between genotypes in aortic VSMs in studies involving migration ( Figure  S5A ), proliferation ( Figure S5B ), osmotic volume regulation ( Figure S5C ), or apoptotic volume regulation ( Figure S5D ).
Discussion
Although human, rat, and mouse K 2P 6 .1s have been cloned and the electrophysiological properties studied in heterologous expression systems, 4, 5, 17 the physiological function of K 2P 6.1 is presently not known. The fact that K 2P 6.1 is highly expressed in all of the blood vessels studied to date 2,7-10 led us to ask questions regarding the functional role of K 2P 6.1 in the vascular system. Our studies reveal the following: (1) K 2P 6.1 influences systemic blood pressure; (2) K 2P 6.1 regulates the contractile state of vascular muscle, likely by setting its membrane potential and rho kinase activity; and (3) K 2P 6.1 does not appear to be involved with VSMC migration, proliferation, or volume regulation in the models tested.
We acknowledge the inherent limitations in the use of a mouse KO model, because pretranslational or posttranslational changes in other genes can occur with gene deletion, especially when the gene deletion leads to pathophysiological conditions, such as hypertension. Further studies into the mechanisms of action of K 2P 6.1 in the vascular system will be needed to develop a clearer picture of its role during normal states and in disease states like hypertension.
At an age of 8 to 12 weeks, cardiac indices were not different between WT and KO mice (Table S2) . However, blood pressure in KO mice was significantly increased in awake and anesthetized mice compared with WT mice (Figure 2A and 2B) . The peripheral vascular resistance increased 42% in KO mice ( Figure 2B and Table S2 ). The increase in peripheral vascular resistance, which is associated with essential hypertension, 18 is likely attributed to peripheral vasoconstriction. Although the present study looked at the aorta, it is noteworthy that smaller vessels also express K 2P 6.1 2,7-10 and are likely responsible for the increased peripheral vascular resistance. Because neurons express little to no K 2P 6.1, 4 -6 a central mechanism for the hypertension in KO mice is not likely. Similarly, K 2P 6.1 appears to have little to no expression in mouse kidney, 6, 19 reducing the possibility of a renal component to the observed hypertension in the KO mice.
Our data strongly suggest that rho kinase is responsible for the enhanced contractions to KCl, BAY K 8644, and U46619 ( Figures 3A, 3B , 4B, and 4C). First, aortic segments from KO mice contracted more to U46619 than did corresponding segments from WT mice ( Figure 4B ). U46619 is an agonist that works exclusively through activation of rho kinase without activation of L-type calcium channels ( Figure S3C and S3D). Therefore, rho kinase in aortic segments from KO mice must be more active at rest, activated more by U46619, or both. Second, pretreatment of aortic segments from KO mice with the rho kinase inhibitor Y27632 normalized the contraction to BAY K 8644 ( Figure 5A and 5B). Third, the addition of nifedipine to arterial segments from KO mice that were precontracted with BAY K 8644 did not relax as much on a percentage basis at concentrations of 10 Ϫ7 and 10
Ϫ6
mol/L as did the segments from WT mice ( Figure S3E ). Because BAY K 8644 contracted aortic segments from KO mice more on an absolute scale (mN of force, see Figure 4C ), then the enhanced force generated in the segments from KO mice is likely attributed to greater activation of rho kinase. When taken together, there are multiple lines of evidence demonstrating enhanced rho kinase activation in aortic rings from KO mice. If, as our data suggest, K 2P 6.1 channels regulate membrane potential in VSMs, then the depolarized state of VSMs may account for the increased rho kinase activity, the increased peripheral vascular resistance, and hypertension observed in the KO mice ( Figure 6 ). Given that K 2P 6.1 is expressed throughout the vascular system, including resistance vessels, 2,7-10 it is highly likely that, in addition to aorta, vascular smooth muscle cells in smaller resistance arteries are also depolarized. Although our data show that there are no differences in densities of L-type calcium channels, the depolarized state of the VSMCs from KO mice confers an increased open-state probability. At the resting membrane potential of Ϫ39 mV in VSMCs of WT mice, there is very little activation of the L-type calcium channels, and influx of extracellular Ca 2ϩ through these channels is minimal. However, at a membrane potential of Ϫ22 mV in VSMCs of KO mice, L-type calcium channels are more activated and do not fully inactivate (window current). 20 Thus, VSMCs from KO mice should have an increased intracellular Ca 2ϩ and, as a consequence, an enhanced contractile state. The depolarized state of VSMCs from KO mice and/or the increased Ca 2ϩ from L-type calcium channels serves to activate rho kinase and render the cell more sensitive to intracellular free Ca 2ϩ [21] [22] [23] ( Figure 6 ). The net results should be an enhanced contractile state of VSM, increased peripheral vascular resistance, and hypertension. 18 
Perspectives
If our observations are translatable to the human, then mutations in the K 2P 6.1 gene that produce a loss of channel function and/or expression could be a genetic contributor to essential hypertension. The National Institutes of Health single nucleotide polymorphism database currently lists 107 human single nucleotide polymorphisms associated with K 2P 6.1. In addition, K 2P 6.1 has a promoter polymorphism that affects both transcription and functional expression. 24 Given that K 2P 6.1 is highly expressed in the vascular system, 2, 9, 10, [25] [26] [27] it is reasonable to speculate that a link between K 2P 6.1 variants and cardiovascular disease, including hypertension, may exist. Polymorphisms in K 2P 6.1 are strongly associated with severity of sickle cell anemia. 28 Of note, sickle cell patients presenting with severe symptoms also experience pulmonary hypertension compared with those patients characterized as having mild symptoms. 29 K 2P 6.1 is among a set of genes of which altered expression patterns appear to predict acute rejection of transplanted hearts. 30 Whether this rejection involves a vascular component of K 2P 6.1 variants is not known. Finally, K 2P 6.1 is included in a gene network that is under overall control of estrogen. 31 Although this association with estrogen may or may not have a link to cardiovascular disease, the fact that estrogen has important regulatory roles in the cardiovascular system is provocative. Given the results of our study in mice and the paucity of human studies dealing with K 2P 6.1 variants, it will be important to take a close look at K 2P 6.1 variants in cardiovascular pathologies.
In summary, functional loss of K 2P 6.1 results in depolarization of VSM that may trigger a cascade of events including enhanced activation of rho kinase. K 2P 6.1 may exert a dilator influence on the vasculature during normal conditions. The loss of function as a result of alterations in K 2P 6.1 expression and/or function may contribute to the pathogeneses of cardiovascular disease.
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Methods
All studies were approved by the Institutional Animal Care and Use Committee at the Baylor College of Medicine.
Generation of K 2P 6.1 Tm(TG0009)Tigm mice (herein referred to as K 2P 6.1 for the background strain) Mice used in this study were made available on a collaborative basis through the Texas A&M Institute for Genomic Medicine (Houston, TX). The knockout strategy was to replace exon 1 of K 2P 6.1 with a selection cassette. Exon 1 encodes the first ~120 aa of the 313 aa protein and contains the coding sequence for the first transmembrane domain, the first pore region, and the site for dimerization ( Figure S1A ). Briefly, a gene replacement targeting vector, pKOS-30, containing the β-galactosidase/neomycin phosphotransferase fusion gene flanked by sections of DNA homologous to the 5' untranslated region and 5' intronic region to exon 1 of K 2P 6.1 (NM_001033525.1) was created. This targeting vector was electroporated into the ES cells (derived from the 129S5/SvEvBrd mouse substrain) for selection of neomycin resistant clones. The ES cells containing the portion of the disrupted K 2P 6.1 gene were confirmed by Southern Blot. The ES cell was introduced into a blastocyst and implanted into a pseudopregnant mouse to create a chimeric mouse. This chimeric mouse was bred on a mixed C57/129 background and used for all K 2P 6.1 studies. Figure S1B details the targeting strategy. Male mice were used in this study.
Genotyping DNA from a 2-mm tail clipping of each mouse at 6 weeks of age was isolated using Qiagen's Blood & Tissue Kit (cat 69506) according to the manufacturer's instructions. 50 ng of purified DNA was used in a 20-μl PCR reaction to identify K 2P 6 ) possess all three bands. Figure S1C shows results from PCR genotyping.
The following genotyping primers were designed by TIGM and synthesized by Invitrogen: K 2P 6.1 + fwd 5'-GAGCTGCCAACGCTTCGG, K 2P 6.1 -fwd 5'-GCAGCGCATCGCCTTCTATC, and K 2P 6.1 rev 5'-CAAGGAAAGCCCTACCAAGG. Primers for lacZ were previously reported 1 : lacZ fwd 5'-GTTGCAGTGCACGGCAGATACACTTGCTGA and lacZ rev 5'-CGGTGACCACACCCGGTATTAAGTTAAGCG.
RNA isolation and real-time PCR To isolate RNA from the thoracic aorta, F1N1 littermate pairs were deeply anesthetized with a ketamine-xylazine-acepromazine combination followed by administration of 50 units of heparin. Under sterile conditions, the abdominal aorta was opened and the thoracic aorta was flushed with ice-cold HBSS via cardiopuncture. The thoracic aorta was carefully removed, placed into a dish containing ice-cold HBSS, and cleaned of connective tissue and fat. The thoracic aorta was blotted on a Kimwipe® and flash frozen in liquid nitrogen. RNA was isolated using the RNeasy Micro System (Qiagen) according to the manufacturer's instructions. Briefly, the aorta was ground with a mortar and pestle under liquid nitrogen, thawed to room temperature with buffer containing guanidine thiocyanate, bound to a silica-based membrane, treated with DNAse to remove trace genomic DNA, and eluted into water for real-time PCR analysis. To isolate RNA from heart, the heart was quickly excised and flushed of blood with ice-cold HBSS. TRIzol LS reagent (Invitrogen) was used with a Dounce homogenizer to disrupt the tissue and lyse the cells. The RNA fraction was isolated and processed according to the manufacturer's instructions, followed by DNAse treatment (Invitrogen). RNA purity was assessed by spectrophotometry with A260/A280 > 1.9. Reverse transcription using random hexamers and Superscript III was carried out using 0.1 μg and 1 μg total RNA for the aorta and heart respectively.
To isolate RNA from endothelial and smooth muscle cell fractions (4) Tie2-GFP mice were used at 8-12 weeks. Tie2 is expressed on endothelial cells and is not expressed on VSMC. Using fluorescent labeled cell sorting on aortic digests (aortas previously flushed of blood) allowed separation of endothelial and VSMC compartments. Thoracic aortas were dissected and digested as described under Electrophysiology Methods. A BD Biosciences FACS Aria II was used to sort GFP + and GFP − fractions directly into collection tubes for RNA extraction. Cell viability determined by propidium iodide uptake was >95%. Post-sort analysis revealed >95% purity in the fractions. RNA was extracted as described above with the exception of using a Qiagen Shredder for homogenization.
Primers were designed using Primer Express 2.0 software. The gene abbreviation is followed by the NCBI accession number and resulting amplicon size: The efficiency of each primer set was determined to be > 95% using high quality RNA from pooled heart and aorta samples. Real-time PCR using SYBR green and GAPDHnormalized expression was performed on WT and KO samples using identical conditions and processed simultaneously for each target and GAPDH. The PCR products were validated by direct sequencing methods (SeqWright, Houston TX).
Electrophysiology
For electrophysiology studies, freshly dispersed aortic VSMC were obtained by enzymatic dissociation using a papain/dithiothreitol cocktail, followed by a collagenase H /hyaluronidase cocktail (Sigma). Electrophysiological studies were measured using an Axopatch 200B integrated patch clamp amplifier and pClamp version 9.2 software. Membrane potential was determined using current clamp (i=0 pA) in the whole cell mode using perforated patches (Amphotericin B). The currents were normalized to individual whole cell conductance and expressed as current density (pA/pF) where noted.
For voltage clamp studies Ba 2+ currents in ruptured patches were measured and used as a surrogate for Ca 2+ . Pipette buffer consisted of (in mmol/L): 140 NMDG-Cl, 1 MgCl 2 , 5 EGTA acid, 1 HEPES, and 3 Na 4 ATP with the pH adjusted to 7.2 with HCl. Bath buffer consisted of (in mmol/L): 135 TEACl, 10 BaCl 2 , 1 MgCl 2 , 10 HEPES, and 10 glucose with the pH adjusted to 7.4 with TEAOH as previously described 2 . P/4 leak subtraction was used with calcium channel currents. Currents during step potentials and voltages during current clamp mode were averaged when the traces were in a steady state condition. Pipettes were pulled and polished to resistances of 5-9 MΩ. Pipette buffer for current clamp studies consisted of (in mmol/L): 100 K-gluconate, 4.3 KCl, 1 MgCl 2 , 0.1 EGTA, 10 HEPES with the pH adjusted to 7.1 with NaOH. Bath buffer consisted of (in mmol/L): 140 NaCl, 3 NaCO 3 , 4.2 KCl, 1.2 KH 2 PO 4 , 0.1 CaCl 2 , 10 glucose, and 10 HEPES with the pH adjusted to 7.4 with NaOH.
Body Composition Analysis A Lunar PIXImus (GE Medical Systems) was used to non-invasively measure bone and tissue composition of 6 littermate pairs of each genotype by a blinded observer.
Non-invasive blood pressure determination by tail plethysmography Blood pressure was measured on 6 littermate pairs of each K 2P 6.1 genotype using tail cuff plethysmography, a six-channel NIBP system, and BPMonWin software. The NIBP system was calibrated to known pressures using an inline mercury bulb sphygmomanometer. The mice were 8-12 weeks in age and weighed from 20 to 32 g. Prior to making the measurements, each mouse was acclimatized to the measuring chambers for 30 min on four consecutive days. Systolic, mean arterial blood pressure and heart rate were recorded by the BPMonWin software automatically based on the flow waveforms and collated by a blinded observer.
Cardiovascular phenotyping of K 2P 6.1 mice Six littermate pairs of K 2P 6.1 mice of each genotype were anesthetized with Nembutal (50 mg/kg, i.p.) (Sigma). Body temperature was monitored and maintained at 37° C. Electrocardiogram was taken from electrodes attached to the paws. Blood flow velocity was measured in the aortic arch and the abdominal aorta using pulsed Doppler ultrasound 3, 4 . Arterial and intraventricular pressures were measured using a Millar catheter/pressure transducer (SPR1000, 1F ~ 0.33mm [Millar Instruments Inc, Houston TX]) inserted into the right carotid artery and advanced into the left ventricle. Cardiac function and coronary flow reserve were assessed from these measurements as previously described [4] [5] [6] [7] .
Histology Aortic rings were fixed in 10% neutral buffered formalin overnight and embedded in paraffin, cross-sectioned at 4 μm, and stained with Verhoeff's Elastic and Masson's Trichrome stain. Images from two consecutive sections were obtained from four equally -spaced locations of the thoracic aorta using a Zeiss Axioplan I microscope with a 5x objective by a blinded observer. The perimeter of the luminal (P Lu ) and abluminal (P Ab ) boundaries of each section of the aorta were measured using Adobe Photoshop CS3 Enhanced. Lumen diameter was calculated by P Lu /π. Wall thickness was calculated by P Ab /2π -P Lu /2π.
Isomeric force from aortic rings Changes in isometric force were measured in aortic ring segments from KO mice and WT littermates (8-12 weeks). Thoracic aortas were harvested as described above and cleaned of connective tissue and visceral fat. The aorta's were cut into 2-mm rings and mounted on metal stirrups attached to a myography (ChuelTech, Houston, TX). Isometric force was measured at 37°C in Krebs buffer (in mmol/L): 119 NaCl, 4. For some studies rings that were treated with LNAME were incubated with 100 μmol/L LNAME for 60 minutes.
Proliferation and Migration Studies
Migration and proliferation were studied in cultured VSMC from KO and WT mice using the Electric Cell-Substrate Impedance Sensing (ECIS) method (Applied Biophysics) 8, 9 . Each well of the ECIS array contained gold electrodes. The technique involves passing very weak currents across ten gold electrodes. As cells proliferate and/or migrate to cover the electrode, electrical resistance and impedance increase while capacitance decreases. As a result the ECIS acts as a biosensor to determine the dynamics of proliferation or migration.
VSMC from WT and KO littermates were cultured from the thoracic aorta 10 , passed three times, and plated in wells of an ECIS eight-well array (8W10E, Applied Biophysics). Cells from a single aorta were plated at a density of 30K cells per well (300 μL total per well) in each of four wells. Resistance or conductance measurements of these four wells were averaged to obtain a single observation. For proliferation studies, the capacitance at 64 kHz was measured every 10 min after seeding VSMC until a plateau was reached indicating confluence. The percent of the electrode area covered by VSMC at each time point was calculated by the following equation 8 For migration studies, VSMC were allowed to grow to confluence in wells of the ECIS array. After reaching confluence, proliferation was inhibited by changing to serum-free medium for 24 hours. Cells over the circular electrodes were killed by applying a potential of 5V delivered at 40 kHz for a duration of 30 seconds 8 . Electrical resistance was measured at 4 kHz every ten minutes as the VSMC migrated over the electrode to replace the killed cells. The migration rate was calculated from the time taken for the electrical resistance measure to plateau; i.e., the time required for cells to migrate inward from the perimeter of the round electrode to the center (125 µm radius).
Cell Volume Regulation Osmotic volume regulation was studied in freshly dispersed thoracic aorta VSMC obtained from littermate pairs of WT and KO mice 11, 12 . Cell volumes were measured before and at 1, 2, 4, and 6 min after reducing the osmotic pressure in the bath buffer by 50%. The isoosmotic bath buffer consisted of (in mmol/L): 145 α-mannitol, 54.8 NaCl, 3 NaCO 3 , 4.2 KCl, 1.2 KH 2 PO 4 , 0.1 CaCl 2 , 10 glucose, and 10 HEPES with the pH adjusted to 7.4 with NaOH (osmolality 290 mOsm/kg). The hypoosmotic bath buffer was identical to the isoosmotic bath but without α-mannitol (osmolality contribution of 145 mOsm/kg). The osmolality of all buffers was assessed using a Wescor Vapro 5520. The average area of cells in each well was determined using Adobe Photoshop CS3 Enhanced perimeter detection and area calculation by automated analysis of all image files with identical conditions. Advanced edge detection algorithms were used to delineate each cell boundary. A single cell was tagged and followed through the experimental conditions generating 5 total image files (baseline, 1, 2, 4, and 6 minutes after changing to the hypoosmotic buffer). On average 11 cells from a single aorta were considered a single observation from each experimental group.
Apoptotic volume decrease was measured in cultured VSMC on their 3 rd passage from WT and KO mice 11, [13] [14] [15] . A single cell was tagged and followed through the experimental conditions generating 5 total image files (baseline, 1, 2, 4, and 6 hours after initiation of apoptosis with 1 μmol/L staurosporine). On average 4 cells from a single aorta were considered a single observation from each experimental group. Cell volumes were measured as described above.
Data analysis:
The data were reported as mean ± standard error of the mean (SEM) or mean ± standard error of the least mean squares (SELMS) as noted. Data was analyzed using the two-way repeated measures analysis of variance followed by post hoc Holm-Sidak analysis when appropriate. Other data was analyzed using the Students T-test with a Bonferroni correction. P values of 0.05 or less were considered significant. Tables and Figures:   Table S1 . Body composition of K 2P 6.1 KO and WT mice. n=6 per experimental group. BMD (bone mineral density), BMC (bone mineral content). 
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